Gait Impairment

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-05-22
Clinical Trial Update: 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study) [Phase 4]
Phase 4 clinical trial update on 1/2-dopaminergic dysfunction in late-life depression (The D3 Study) has terminated with results posted.